Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Segmental neurofibromatosis.

Erwin S Schultz1, Dieter Kaufmann, Sigrid Tinschert

  • 1Department of Dermatology, University of Erlangen-Nuremberg, Germany. schultz@derma.imed.uni-erlangen.de

Dermatology (Basel, Switzerland)
|June 22, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sorafenib as first-line therapy for metastatic uveal melanoma: A multicenter, placebo-controlled randomized discontinuation study (STREAM).

iScience·2025
Same author

Hereditary diffuse gastric cancer spectrum associated with germline <i>CTNNA1</i> loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls.

Gut·2025
Same author

[Dupilumab mediated acute eosinophilic sydrome with pneumonia].

MMW Fortschritte der Medizin·2025
Same author

Low-dose total skin electron beam therapy in erythrodermic mycosis fungoides and Sézary syndrome: Results From the Prospective S-MISR Study.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2025
Same author

Shprintzen-Goldberg syndrome: follow-up of the cardiovascular features in an international cohort of 29 patients with SGS.

Journal of medical genetics·2025
Same author

[Adjuvant and neoadjuvant therapy of melanoma].

Deutsche medizinische Wochenschrift (1946)·2025
Same journal

Survey on Difficult to Treat Tinea: A Sub-Saharan Africa Snapshot.

Dermatology (Basel, Switzerland)·2026
Same journal

Mpox Outbreaks Beyond Historically Endemic Regions: A Clinical Review of Vaccination Strategies and Public Health Challenges.

Dermatology (Basel, Switzerland)·2026
Same journal

Clinical Insights and Prognostic Factors in Frontal Fibrosing Alopecia and Lichen Planopilaris: A Retrospective Cohort Study.

Dermatology (Basel, Switzerland)·2026
Same journal

Descriptive Analysis of DRESS Reports from EudraVigilance and DRESS Cases from the RegiSCAR-project.

Dermatology (Basel, Switzerland)·2026
Same journal

The Role of the Vagus Nerve and Its Stimulation in Modulating Inflammatory Skin Diseases and Other Dermatologic Conditions: From Mechanisms to Therapeutics.

Dermatology (Basel, Switzerland)·2026
Same journal

Skin Barrier Dysfunction, Antimicrobial Peptide Alterations, and Microbiome Changes in Solid Cancer Patients Treated with Epidermal Growth Factor Receptor Inhibitors.

Dermatology (Basel, Switzerland)·2026
See all related articles

Segmental neurofibromatosis (NF1) involves limited skin lesions. This study found no NF1 gene mutation in patient fibroblasts, suggesting mutations in Schwann cells are key for neurofibroma development.

Area of Science:

  • Genetics
  • Dermatology
  • Oncology

Background:

  • Segmental neurofibromatosis (NF1) presents with localized cutaneous neurofibromatosis type 1 lesions.
  • The prevailing hypothesis suggests segmental NF arises from postzygotic mutations in the NF1 gene.
  • Previous research supported this by identifying NF1 microdeletions in fibroblasts from affected skin areas.

Observation:

  • This study investigated a patient with segmental NF, examining fibroblasts from neurofibromas.
  • Standard mutation detection methods, including protein truncation test, enzymatic mutation detection, and fluorescence in situ hybridization, were employed.
  • No NF1 gene mutations were detected in the fibroblasts cultured from the patient's neurofibromas.

Findings:

  • The absence of detectable NF1 gene mutations in fibroblasts contradicts previous findings in similar cases.

Related Experiment Videos

  • These results indicate that fibroblast mutations may not be the primary driver for neurofibroma formation in all segmental NF cases.
  • The data support the concept that NF1 mutations specifically within Schwann cells are crucial for the development of neurofibromas.

    • Implications:

    • This research refines our understanding of the genetic basis of segmental neurofibromatosis.
    • It highlights the critical role of Schwann cells in neurofibroma pathogenesis, differentiating from fibroblast involvement.
    • Further investigation into cell-specific mutations in NF1 is warranted to clarify disease mechanisms and potential therapeutic targets.